Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$44.6b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Ascentage Pharma Group International

Market Cap: HK$19.4b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

L&C BIOLTD

Market Cap: ₩1.8t

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

Clinuvel Pharmaceuticals

Market Cap: AU$461.4m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Jiangxi Fushine Pharmaceutical

Market Cap: CN¥10.1b

Engages in the research, development, production, and sale of APIs and pharmaceutical intermediates in China and internationally.

Rubicon Research

Market Cap: ₹148.1b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Precigen

Market Cap: US$1.4b

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Oscotec

Market Cap: ₩2.1t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

ALTEOGEN

Market Cap: ₩19.6t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

HansBiomed

Market Cap: ₩489.2b

Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

Bonesupport Holding

Market Cap: SEK 18.0b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Guangzhou Innogen Pharmaceutical Group

Market Cap: HK$9.2b

Engages in the development of drugs.

Neuland Laboratories

Market Cap: ₹196.3b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Clarity Pharmaceuticals

Market Cap: AU$1.2b

A clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States.

Egetis Therapeutics

Market Cap: SEK 2.1b

A pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally.

Clene

Market Cap: US$74.3m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

3billion

Market Cap: ₩404.6b

Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.

Newron Pharmaceuticals

Market Cap: CHF 342.0m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Bio SolutionLtd

Market Cap: ₩305.0b

Develops, manufactures, and sells cell therapy products worldwide.

Mesoblast

Market Cap: AU$2.9b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Guard Therapeutics International

Market Cap: SEK 25.2m

A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.

Pharma Mar

Market Cap: €1.7b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

OSE Immunotherapeutics

Market Cap: €74.6m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Abeona Therapeutics

Market Cap: US$313.8m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

Forum Markets

Market Cap: US$87.1m

Forum Markets, Incorporated, doing business as Forum, operates a technology company focused on Ethereum-based infrastructure for the tokenization of real-world assets.

Ocumension Therapeutics

Market Cap: HK$6.7b

Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.

Aether Industries

Market Cap: ₹156.5b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Hyperion DeFi

Market Cap: US$50.8m

An ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.

Grace Therapeutics

Market Cap: US$71.2m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

Eton Pharmaceuticals

Market Cap: US$683.2m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Kuros Biosciences

Market Cap: CHF 976.2m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

IDL Diagnostics

Market Cap: SEK 90.5m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.4b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Shanghai OPM Biosciences

Market Cap: CN¥7.3b

Provides cell culture media and CDMO services in China and internationally.

Senores Pharmaceuticals

Market Cap: ₹41.2b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

Caliway Biopharmaceuticals

Market Cap: NT$168.1b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.